Kay NE - Search Results

1

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia.

Kay NE, Geyer SM, Call TG, Shanafelt TD, Zent CS, Jelinek DF, Tschumper R, Bone ND, Dewald GW, Lin TS, Heerema NA, Smith L, Grever MR, Byrd JC. Kay NE, et al. Blood. 2007 Jan 15;109(2):405-11. doi: 10.1182/blood-2006-07-033274. Epub 2006 Sep 28. Blood. 2007. PMID: 17008537 Free PMC article. Clinical Trial.

2

Expansion of a lymphocyte population co-expressing T4 (CD4) and T8 (CD8) antigens in the peripheral blood of a normal adult male.

Kay NE, Bone N, Hupke M, Dalmasso AP. Kay NE, et al. Blood. 1990 May 15;75(10):2024-9. Blood. 1990. PMID: 2140062 Free article.

3

Chronic lymphocytic leukemia: recommendations.

Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Oken MM, Schiffer CA, Keating MJ, Boldt DH, Kempin SJ, et al. Cheson BD, et al. Among authors: kay ne. Ann Intern Med. 1989 Apr 15;110(8):664-5. doi: 10.7326/0003-4819-110-8-664. Ann Intern Med. 1989. PMID: 2930097 No abstract available.

4

The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors.

Kay NE, Burton J, Wagner D, Nelson DL. Kay NE, et al. Blood. 1988 Aug;72(2):447-50. Blood. 1988. PMID: 3135858 Free article.

5

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.

Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ, et al. Cheson BD, et al. Among authors: kay ne. Am J Hematol. 1988 Nov;29(3):152-63. doi: 10.1002/ajh.2830290307. Am J Hematol. 1988. PMID: 3189311

6

Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group.

Kay NE, Oken MM, Bone N, Kyle RA, Greipp P, Van Ness B, Leong T. Kay NE, et al. Blood. 1995 Nov 15;86(10):4000-1. Blood. 1995. PMID: 7579374 Free article. No abstract available.

7

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. Cheson BD, et al. Blood. 1996 Jun 15;87(12):4990-7. Blood. 1996. PMID: 8652811 Free article. No abstract available.

8

Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial.

Kay NE, Leong T, Kyle RA, Greipp P, Billadeau D, Van Ness B, Bone N, Oken MM. Kay NE, et al. Blood. 1997 Jul 1;90(1):340-5. Blood. 1997. PMID: 9207470 Free article. Clinical Trial.

9

Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.

Greipp PR, Leong T, Bennett JM, Gaillard JP, Klein B, Stewart JA, Oken MM, Kay NE, Van Ness B, Kyle RA. Greipp PR, et al. Among authors: kay ne. Blood. 1998 Apr 1;91(7):2501-7. Blood. 1998. PMID: 9516151 Free article. Clinical Trial.

10

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

Kay N, Leong T, Kyle RA, Greipp P, Van Ness B, Bone N, Oken MM. Kay N, et al. Leuk Lymphoma. 1999 Mar;33(1-2):127-33. doi: 10.3109/10428199909093733. Leuk Lymphoma. 1999. PMID: 10194129 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page